Publication | Closed Access

Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study

Nvalt 5Surgical OncologyMedicineCancer ManagementActive Supportive CareCancer TreatmentOncologyRadiation OncologyPhase 3